Top Companies Leading the Global Myelofibrosis Treatment Market

Incyte Corporation, Novartis AG, Celgene Corporation, Eli Lilly and Company, Gilead Sciences, Inc., among others, are the major players in the global myelofibrosis treatment market.

The global myelofibrosis treatment market is expected to be aided by the growth of the global market for blood and bone marrow cancer treatment which is projected to grow at a CAGR of 7% in the forecast period of 2022-2027. As per the analysis by Expert Market Research, the myelofibrosis treatment market is expected to be driven by the various research and development (&D) activities aimed at exploring the potential of myelofibrosis treatment.

Supported by governments in developing and developed countries, an increasing number of investments in research and technology advancements for developing medical equipment for treating myelofibrosis at low costs are factors bolstering the market growth. Easy availability of the raw material for making medicine additionally favours the upward movement of the market.

Incyte Corporation (NASDAQ: INCY), a leading player in the medical sector, offers an elaborated patient assistance programme, IncyteCARES, which refers to Connecting to Access, Reimbursement, Education and Support. It connects patients with support and resources during the treatment with Jakafi, and further offers access to trained nurse professionals and financial support in addition to other resources for eligible patients. Jakafi is a first-in-class JAK1/JAK2 inhibitor approved by the United States Food and Drug Administration for treating people with intermediate or high-risk myelofibrosis. It is marketed by Incyte in the United States and by Novartis as Jakavi® (ruxolitinib) in regions outside the United States.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Top 5 Myelofibrosis Treatment Companies in the World:

Incyte Corporation

Incyte Corporation is an American pharmaceutical company that thrives on finding solutions for critical medical needs through discovery, development, and commercialisation of novel medications. Aided by a strong team of scientists, the company is advancing in the field of oncology and inflammation & autoimmunity. The company is driven by nearly 1700 employees and has operations in North America, Europe, and Asia. Incyte has been recognised by Forbes as one of the World’s Most Innovative Companies.

Novartis AG

Based out of Switzerland, Novartis International AG is a multinational, and considered among the largest pharmaceutical companies in the world. It is a member of multiple associations, including the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), the European Federation of Pharmaceutical Industries and Associations (EFPIA), and the Pharmaceutical Research and Manufacturers of America (PhRMA). Novartis leverages machine learning and automation to drive a faster, more innovative way to navigate new drugs and is consistently ranked among the top companies investing in research and development. Supported by a workforce of about 1,25,000, the company has a worldwide presence in over 140 countries.

Celgene Corporation

Celgene Corporation is a pharmaceutical company that is famously known for the discovery, development, and commercialisation of cancer and immunology drugs through gene and protein regulation. Its primary product is Revlimid (lenalidomide), which is used to treat multiple myeloma and certain anaemias. Its cancer drugs include Pomalyst (pomalidomide), and Revlimid (lenalidomide), and it also produces an immunology drug Otezla (apremilast). The company employees a workforce of over 7,000 people located in over 60 countries around the world.

Eli Lilly and Company

Eli Lilly and Company is a pharmaceutical company based out of the United States with offices in 18 countries, and a product reachability of nearly 125 countries. Eli Lilly and Company creates and actively participates in online communities, sharing reliable information through easily accessible means. Lilly is focused on making medicines for chronic diseases like diabetes, heart disease, bone health, and cancer.

Gilead Sciences, Inc.

Gilead Sciences, Inc. is a biopharmaceutical company based out of California that has a focus on the research and development of antiviral drugs utilised for the treatment of conditions such as HIV, hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi. It has locations in more than 24 countries and has 12,000 employees.

Also Read@ https://www.expertmarketresearch.com/pressrelease/global-myelofibrosis-treatment-market